FMOC-Lys(Me)2-OH HCl, 95.0%, 10g

2-Hydroxy-1-naphthaldehyde>98.0%(GC)(T)25g

((2R,3R,4S,5R)-3-(Benzoyloxy)-5-bromo-4-fluorotetrahydrofuran-2-yl)methyl benzoate, 97%, 25g

1-methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine 1,4-dioxide (Imatinib Impuruity), 97%, 50mg

TERT-BUTYL 3-METHYL-4-NITROPHENYLCARBAMATE, 95.0%, 1g

(S)-1-(3-Bromophenyl)ethanamine hydrochloride, 97%, 10g

(2,4-Dioxo-3,4-dihydro-2 H -pyrimidin-1-yl)-acetic acid, 95.0%, 25g

(5-Chlorobenzo[d][1,3]dioxol-4-yl)boronic acid, 98%, 5g

(2S)-2-Amino-2,3-dimethylbutanoic acid, 95.0%, 250mg

1-(Pyridin-3-yl)butan-1-amine, 95+%, 100mg

(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione, 95.0%, 500g

1-Chloro-3-fluoro-5-methoxy-2-nitrobenzene, 97.0%, 5g

Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate, 95.0%, 10g